Why Farbe Firma is the Top Manufacturer of Tigecycline for Injection
- Maulik Sudani
- 40 minutes ago
- 5 min read
Last Updated: May 21, 2026
TL;DR: Tigecycline for Injection — tigecycline, the first glycylcycline antibiotic, supplied as a lyophilised powder reconstituted to a sterile parenteral solution — is the broad-spectrum agent hospitals use against complicated multidrug-resistant infections, including MRSA, vancomycin-resistant enterococci and ESBL-producing Enterobacteriaceae in complicated skin, intra-abdominal and respiratory infections. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Tigecycline for Injection at our Gujarat, India facility and supplies it to hospital tenders, distributors and brand owners in 30+ countries.
Key Takeaways
Drug class: Glycylcycline antibiotic (a structural derivative of minocycline); a broad-spectrum reserve agent active against MRSA, VRE, ESBL-producing Enterobacteriaceae and many anaerobes in complicated skin, intra-abdominal and community-acquired respiratory infections.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified lyophilisation lines with nitrogen-overlay and light-protection controls, and dedicated antibiotic handling zones with full cleaning verification.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, drug master files and CEP-style documentation for registrations across regulated and emerging markets.
End-to-end CMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready packaging and cold-chain coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
Introduction: Why Tigecycline for Injection Demands a Premium Manufacturer
Tigecycline for Injection occupies a specific and difficult place in hospital pharmacy: it is one of the few intravenous antibiotics that still works when the common options have failed. As the first member of the glycylcycline class, tigecycline was engineered to evade the two main tetracycline-resistance mechanisms — ribosomal protection and efflux pumps — which is why it retains activity against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, ESBL-producing Escherichia coli and Klebsiella, and a wide range of anaerobic pathogens. Clinicians reach for it in complicated skin and skin-structure infections, complicated intra-abdominal infections and community-acquired bacterial pneumonia, often as part of combination therapy for serious resistant disease.
That clinical role places unusual demands on the manufacturer. Tigecycline is supplied as a lyophilised powder for reconstitution — typically a 50 mg vial — and the molecule is both oxygen-sensitive and light-sensitive. Exposure to air during processing can drive oxidative degradation, and the reconstituted solution must retain its characteristic orange colour as an integrity cue. Producing it correctly means controlled-headspace filling, nitrogen overlay, light-protected handling, validated lyophilisation cycles and stability data proving potency survives hot-climate shipment. Choosing a Tigecycline for Injection manufacturer that treats oxidation control and aseptic lyophilisation as core engineering disciplines — not afterthoughts — is what keeps a fragile supply chain dependable.
What Sets a World-Class Tigecycline for Injection Manufacturer Apart
A world-class manufacturer of Tigecycline for Injection invests in three areas competitors often underinvest in: oxidation-controlled lyophilisation, antibiotic-segregated facility flow, and a stability programme that mirrors real-world distribution. Oxidation-controlled lyophilisation goes beyond running a freeze-dryer — it means inert-gas blanketing of the bulk solution, low-oxygen headspace at stoppering, mapped shelf-temperature uniformity, verified primary and secondary drying cycles, residual moisture below specification on every vial, and post-lyophilisation container-closure integrity testing to confirm vacuum levels and stopper seating.
Antibiotic-segregated flow matters because glycylcyclines, like beta-lactams, lincosamides and other potent antibiotic classes, require controlled handling: dedicated change-over rooms, validated cleaning down to documented residue limits, swab-and-rinse verification, separate HVAC zones, and a toxicological assessment proving cross-contamination stays well below clinically meaningful thresholds. World-class plants do all of this and document it cleanly for audit, supported by electronic batch records that lock deviations the moment they occur and by light-protected staging that shields the product from filling through to final packaging.
Quality Systems Behind Every Tigecycline for Injection
Every Farbe Firma Tigecycline for Injection batch is released only after a full stack of quality checks: identity and assay by validated stability-indicating HPLC against USP, BP or EP reference standards, residual moisture by Karl Fischer titration, pH after reconstitution, particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration in dedicated isolators, and related-substances profiling to confirm oxidative degradation products stay within the appropriate monograph limits. Certificates of analysis are issued with full traceability back to API lot, excipient lot, primary-packaging lot and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous monitoring, calibrated sterilisation and depyrogenation tunnels, validated and inert-gas-protected lyophilisation recipes, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (25 °C / 60 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included — so we can assure customers the Tigecycline for Injection they buy today will meet specification when it reaches the patient months later in any climate.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Tigecycline for Injection Manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across antibiotics, analgesics, anaesthetics, anti-emetics and critical-care categories. For Tigecycline for Injection specifically, we supply the 50 mg lyophilised vial presentation as standard, with custom potencies, fill volumes and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier ready to hand for registration in the buyer's target market.
Our CDMO services scale cleanly from hospital pharmacy supply to full national tender procurement. We prepare full eCTD and ACTD modules, drug master files, ICH Q1A stability packages, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate cold-chain shipping where the destination requires it. When a buyer needs Tigecycline for Injection on a tight deadline, our regulatory, manufacturing and logistics teams move as one — dossier, artwork, production slot and shipment plan delivered as a single coordinated package, with a single accountable point of contact.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor; our quality unit responds to technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through formulation, oxidation control, lyophilisation, container-closure and stability choices in real detail. For a last-line parenteral antibiotic where dosing accuracy and sterility decide patient outcomes, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Tigecycline for Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Tigecycline for Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified lyophilisation lines, qualified water-for-injection systems and validated environmental monitoring. WHO-GMP, USP, BP, IP and EP compliance documentation is available on request.
Which potency and pack size of Tigecycline for Injection do you supply?
Our standard presentation is tigecycline 50 mg lyophilised powder in a single-dose vial for reconstitution and intravenous infusion. Custom fill weights, vial closures and multi-pack configurations are available under contract manufacturing agreements — share your specification and our technical team will quote within 48 hours.
Can Farbe Firma support country-specific registrations for Tigecycline for Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability packages (long-term and accelerated), and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets. Our regulatory team has supported registrations across 30+ countries in Africa, LATAM, CIS, GCC, MENA and Southeast Asia.
How does Farbe Firma protect tigecycline from oxidation and light degradation?
Tigecycline is oxygen- and light-sensitive, so the bulk solution is prepared under nitrogen blanket, vials are filled with controlled low-oxygen headspace, and product is handled under light-protected conditions from filling through final packaging. Oxidative related substances are monitored on every batch by validated stability-indicating HPLC against monograph limits.
What is the minimum order quantity for Tigecycline for Injection contract manufacturing?
MOQs vary by potency, label complexity and dossier requirements. For the standard 50 mg lyophilised vial presentation we accommodate hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation against your specification.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments